Thursley, United Kingdom

Christopher Noon

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Thursley, GB (2013)
  • Dublin, CA (US) (2013)

Company Filing History:


Years Active: 2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Christopher Noon

Introduction

Christopher Noon is an accomplished inventor based in Thursley, GB. He has made significant contributions to the field of clinical trials through his innovative patents. With a total of 2 patents, his work focuses on enhancing the efficiency and effectiveness of clinical trial protocols.

Latest Patents

One of Christopher Noon's latest patents is a system designed to assist in the creation of clinical trial protocols. This system allows users to instantiate protocol elements in a structured database, which can then be utilized to develop various protocol-related documents. The system aids users in selecting tasks for the study by referencing a historical database of tasks linked to similar protocols. It automatically generates complex content from the database and can render overlapping protocol elements differently at various locations within the document. Additionally, the system provides advisories to indicate incomplete aspects of the document or highlight issues deemed important by sponsoring authorities. Once all protocol elements are instantiated, the database can drive most downstream operations of the study.

Career Highlights

Christopher Noon is currently employed at Medidata Solutions, Inc., where he continues to innovate in the realm of clinical trials. His work has been instrumental in streamlining processes and improving the quality of clinical research.

Collaborations

Some of his notable coworkers include Carol A Broverman and Michael G Kahn, who contribute to the collaborative environment at Medidata Solutions, Inc.

Conclusion

Christopher Noon is a notable inventor whose work in clinical trial protocols has the potential to transform the industry. His innovative patents reflect a commitment to improving research methodologies and enhancing the overall efficiency of clinical studies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…